Počet záznamů: 1
Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A
- 1.0191306 - UMG-J 20010376 RIV GR eng J - Článek v odborném periodiku
Indrová, Marie - Bubeník, Jan - Šímová, Jana - Bieblová, Jana - Jandlová, Táňa - Šmahel, M. - Vonka, V. - Glazman-Kusnierczyk, H. - Pajtasz-Piasecka, E. - Radzikowski, C. - Mikyšková, Romana
Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A.
Oncology Reports. Roč. 8, č. 6 (2001), s. 1371-1374. ISSN 1021-335X. E-ISSN 1791-2431
Grant CEP: GA MZd NC5526; GA MZd NC5900; GA ČR GA312/99/0542; GA ČR GA301/01/0985; GA ČR GA301/00/0114; GA AV ČR IAA7052002
Výzkumný záměr: CEZ:AV0Z5052915
Klíčová slova: chemoimmunotherapy * murine * neoplasms
Kód oboru RIV: EB - Genetika a molekulární biologie
Impakt faktor: 1.224, rok: 2001
In two tumour models, 3MC-induced MHC class I + sarcoma Mc12 HPV 16 E6/E7 oncogene-induced MHC class I - carcinoma MK16, the effectiveness of combined chemoimmunotherapy with ifosfamide derivative CBM-4A and GM-CSF was investigated. In both types of tumours, the combined chemoimmunotherapy can inhibit tumour progression more effectively than GM-CSF therapy or chemotherapy alone.
Trvalý link: http://hdl.handle.net/11104/0087061
Počet záznamů: 1